Evidence map›Paper›PMID 31216667›Full record

ArticleNutrients2019

Water-Soluble Extract from

Wonwoo Lee, Yoonseon Jeong, Jong-Hyung Park, Chang Hyung Lee, Nayoung Yun, Doo Suk Lee, In-Jeong Nam, Jung-Dong Kim, Kee Dong Yoon, Miwon Son and 1 more

Open access · goldAbstract read
In one paragraph

Article in Nutrients, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Wonwoo LeeR&D Center for Innovative Medicines, Helixmith Co., Ltd., Seoul 08826, Korea. wwlee@helixmith.com.
Yoonseon JeongR&D Center for Innovative Medicines, Helixmith Co., Ltd., Seoul 08826, Korea. ysjeong@helixmith.com.
Jong-Hyung ParkR&D Center for Innovative Medicines, Helixmith Co., Ltd., Seoul 08826, Korea. jhpark@helixmith.com.
Chang Hyung LeeR&D Center for Innovative Medicines, Helixmith Co., Ltd., Seoul 08826, Korea. chlee@helixmith.com.
Nayoung YunR&D Center for Innovative Medicines, Helixmith Co., Ltd., Seoul 08826, Korea. nyyun@helixmith.com.
Doo Suk LeeR&D Center for Innovative Medicines, Helixmith Co., Ltd., Seoul 08826, Korea. dslee@helixmith.com.
In-Jeong NamR&D Center for Innovative Medicines, Helixmith Co., Ltd., Seoul 08826, Korea. ijnam@helixmith.com.
Jung-Dong KimR&D Center for Innovative Medicines, Helixmith Co., Ltd., Seoul 08826, Korea. jdkim@helixmith.com.
Kee Dong YoonCollege of Pharmacy, The Catholic University of Korea, Bucheon 14662, Korea. kdyoon@catholic.ac.kr.
Miwon SonR&D Center for Innovative Medicines, Helixmith Co., Ltd., Seoul 08826, Korea. mwson@helixmith.com.
Sunyoung KimR&D Center for Innovative Medicines, Helixmith Co., Ltd., Seoul 08826, Korea. sk@helixmith.com.
Helixmith (South Korea) · KRCatholic University of Korea · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

With a complex etiology involving multiple factors, the condition known as itch is a primary symptom of many skin diseases. Current treatment methods are ineffective for addressing itches caused by dry skin, for example. We developed a botanical extract, ACTPER, made from a mixture of

Indexed as

ActinidiaAnimalsCell LineFilaggrin ProteinsHumansIntermediate Filament ProteinsKeratinocytesMiceMolecular Docking SimulationPerilla frutescensPlant ExtractsPruritusReceptors, Aryl HydrocarbonSignal TransductionSkinUp-RegulationFilaggrin ProteinsFLG protein, humanIntermediate Filament ProteinsPlant ExtractsReceptors, Aryl HydrocarbonWaterACTPERAhRdry-skinfilaggrinitch

Identifiers

PMID31216667
PMCPMC6627490
OpenAlexW2949283125

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.